Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids
Phase 2
Active, not recruiting
- Conditions
- Opioid Withdrawal (Disorder)
- Interventions
- Other: Standard of Care without LofexidineDrug: Standard of Care with Lofexidine
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2025-10-01
- Lead Sponsor
- BioCorRx Pharmaceuticals Inc
- Target Recruit Count
- 24
- Registration Number
- NCT06047834
- Locations
- 🇺🇸
Marshall Health, Huntington, West Virginia, United States
News
No news found